跳至主要内容
临床试验/NCT06417450
NCT06417450已完成不适用

Utility of NESA Microcurrents in the Treatment of Sleep Disturbances, Disruptive Behaviours of Children With Autism Spectrum Disorders and in the Quality of Life of the Family Unit.

University of Las Palmas de Gran Canaria2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年5月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Measuring sleep habits with the Children's Sleep Habits Questionnaire scale

研究概览

简要总结

The term or definition of Autism Spectrum Disorder (ASD) defines a pervasive neurodevelopmental disorder in which deficits in communication and social interaction, altered sensorimotor behaviours, repetitive, restricted and stereotyped interests and activities are observed.

One of the disorders most frequently associated with ASD, and which most affects the quality of life of the child and his or her family, is sleep disorders; it is estimated that between 50 and 80 percent of children with ASD present this alteration and generally continue to suffer from it in adolescence and adulthood; It has also been observed that there is a correlation between sleep problems and an increase in aggressive behaviour, social and emotional deficits and deficits in activities of daily living, which severely affects the child and his or her close family environment; they become emotionally destabilised in a notorious way, and this has a negative impact on their work and productive environment.

The microcurrents generated by the non-invasive neuromodulation device introduce, by means of a non-invasive technique (surface electrodes), electrical energy to normalise the nervous stimulus. This makes it an excellent complementary treatment to the activity of rehabilitation treatment. Its effects are achieved by establishing several input nerve pathways corresponding to the body's dermis, through which the signals are intellectualised in time-space. These signals are the basis for achieving normalisation of the nerve impulse by means of microcurrents.

详细描述

The main objective will be to test the influence of surface neuromodulation applied NESA on sleep disturbances in children with Autism Spectrum Disorders and how this is related to disruptive behaviours and quality of life in the family environment.

It is estimated to take 8 months from the design, management and development of the project, and does not have sources of funding.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children with a diagnosis of Autistic Spectrum Disorder, attending school in the City of San Juan de Dios in Las Palmas de Gran Canaria.
  • Children with symptoms related to sleep disturbances.
  • Children who present episodes of disruptive behaviour.
  • Children who may present sensory alterations or cognitive deficits.
  • Children whose parents sign the informed consent form.

排除标准

  • Present some of the contraindications for treatment with NESA XSIGNAL®: pacemakers, internal haemorrhages, not applying electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia of electricity.
  • If parents do not sign the informed consent form.
  • Presence of uncontrolled convulsions.

结局指标

主要结局

Measuring sleep habits with the Children's Sleep Habits Questionnaire scale

时间窗: Measurement of change: before treatment (baseline), at two months (end of treatment).

Each scored question is rated on a 3-point scale as occurring "usually" (i.e., 5-7 times within the past week), "sometimes" (i.e., 2-4 times within the past week), or "rarely" (i.e., never or 1 time within the past week).

Change in sleep quality with the Sleep Disturbance Scale for Children (SDSC)

时间窗: Measurement of change: before treatment (baseline), at two months (end of treatment).

The Sleep Disturbance Scale for Children (SDSC) will be used. The SDSC is a 26-item scale developed to assess the presence of sleep difficulties in children within the previous six months. The measure is completed by the parent of the child and takes approximately 5-10 min to complete. Item 1 measures the child's average hours of sleep, from 1 ('9 - 11 h') to 5 ('less than 5 h').

Change in parent´s sleep quality with the Pittsburgh Sleep Quality Index (PSQI)

时间窗: Measurement of change: before treatment (baseline), at two months (end of treatment).

The investigators want to see if there are improvements in the quality, efficiency, and quantity of sleep. The Pittsburgh Sleep Quality Index (PSQI) will be combined to report changes in the patient's sleep quality. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality. Adding up the average scores of the seven factors gives a global PSQI score from 0 to 21, with 0-4 indicating "good" sleep and 5-21 indicating "poor" sleep

次要结局

  • Change in parental satisfaction with the Parent Satisfaction Questionnaire (PSQ - FS)(Measurement of change: before treatment (baseline), at two months (end of treatment).)
  • Change in the stress level of parents with the Change in the stress level of parents(Measurement of change: before treatment (baseline), at two months (end of treatment).)
  • Changes to the Register of Disruptive Behaviour Scores with the Aberrant Behavior Checklist (ABC-C)(Measurement of change: before treatment (baseline), at two months (end of treatment).)

研究者

发起方
University of Las Palmas de Gran Canaria
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aníbal Báez Suárez

Clinical Professor

University of Las Palmas de Gran Canaria

研究点 (2)

Loading locations...

相似试验